Is enteral administration of fluorine-18-fluorodeoxyglucose (F-18 FDG) a palatable alternative to IV injection? Pre-clinical evaluation in normal rodents

Nuclear Medicine and Biology

Volumn 29, Issue 3, 2002, Pages 363-373

  Higashi, T ^a   Fisher, S J ^a   Nakada, K ^a   Romain, D J ^a   Wahl, R L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

2 18F fluoro 2 deoxy D glucose; Gastric emptying; Gastrointestinal tract; Glucose absorption

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HYPERTONIC SOLUTION; HYPOTONIC SOLUTION; ISOTONIC SOLUTION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; GASTROINTESTINAL ABSORPTION; GLUCOSE ABSORPTION; NONHUMAN; RADIOACTIVITY; RAT; STOMACH CONTENT; TISSUE DISTRIBUTION;

ANIMALS; FEMALE; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL CONTENTS; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTUBATION, GASTROINTESTINAL; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0036205097     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00312-2     Document Type: Article

References (32)

1. Effects of increasing solid component size of a mixed solid/liquid meal on solid and liquid gastric emptying
2. The fate of sugar in the animal body. I. The rate of absorption of hexoses and pentoses from the intestinal tract
3. PET studies in epilepsy
4. Water absorption and swelling in the rat small intestine in vitro
5. Luminal glucose concentrations in the gut under normal conditions
6. Mechanism by which glucose stimulates the passive absorption of small solutes by the human jejunum in vivo
7. Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose
8. Body size and energy metabolism
9. Whole body FDG-PET for tumor detection should be imaged at 2hr after injection
10. Metabolic imaging by positron emission tomography in oncology
11. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: Demonstration of principle
12. Effect of size and density on canine gastric emptying of nondigestible solids
13. Human postprandial gastric emptying of 1-3-millimeter spheres
14. Delayed FDG-PET scan for differentiation between malignant and benign lesions in the pancreas
15. Mechanism of delayed hepatic glycogen synthesis after an oral galactose load vs. an oral glucose load in adult rats
16. Positron emission tomography: Background, possibilities and perspectives in neuroscience
17. Sugar binding to Na+/glucose cotransporters is determined by the carboxyl-terminal half of the protein
18. On the coupling of membrane digestion with intestinal absorption of sugars and amino acids
19. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat
20. Triiodothyronine stimulates 2-deoxy-D-glucose uptake by organ cultured embryonic chick small intestine
21. Luminal fructose modulates fructose transport and GLUT-5 expression in small intestine of weaning rats
22. Current status of viability assessment with positron tomography
23. Structure of the human Na+/glucose cotransporter gene SGLT1
24. Overview of the current status of PET in breast cancer imaging
25. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts, feasibility studies for cancer imaging with positron-emission tomography
26. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes
27. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
28. Serum glucose: Effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma
29. 'Active' sugar transport in eukaryotes
30. Mechanisms of Na(+)-glucose cotransport
31. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction
32. Glucose transporter gene expression in lactating bovine gastrointestinal tract